Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with retinoic acid in malignant melanoma.

被引：0
|
作者：
Kato, Y
Wang, XF
Qian, DZ
Wei, YF
Zhang, L
Atadja, P
Pili, R
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6253S / 6253S
页数：1
相关论文
共 50 条
  • [31] Preclinical efficacy, toxicology and pharmacokinetics of NVP-LAQ824, a novel synthetic histone deacetylase inhibitor
    Remiszewski, S
    Bontempo, J
    Cohen, P
    Cramer, JA
    Lassota, P
    Hug, M
    Perez, LB
    Thomas, HA
    Versace, R
    Atadja, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S98 - S99
  • [32] Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824
    Atadja, P
    Gao, L
    Kwon, P
    Trogani, N
    Walker, H
    Hsu, M
    Yeleswarapu, L
    Chandramouli, N
    Perez, L
    Versace, R
    Wu, A
    Sambucetti, L
    Lassota, P
    Cohen, D
    Bair, K
    Wood, A
    Remiszewski, S
    CANCER RESEARCH, 2004, 64 (02) : 689 - 695
  • [33] Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B
    Fuino, L
    Bali, P
    Wittmann, S
    Donapaty, S
    Guo, F
    Yamaguchi, H
    Wang, HG
    Atadja, P
    Bhalla, K
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (10) : 971 - 984
  • [34] Mechanisms of radiosensitization by the inhibitor of histone deacetylase NVP-LAQ824 in human lung carcinoma tumor models
    Geng, L
    Fu, A
    Osusky, K
    Huamani, J
    Hallahan, DE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S396 - S397
  • [35] Phase I Pharmacokineitic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
    de Bono, Johann S.
    Kristeleit, Rebecca
    Tolcher, Anthony
    Fong, Peter
    Pacey, Simon
    Karavasilis, Vasilios
    Mita, Monica
    Shaw, Heather
    Workman, Paul
    Kaye, Stan
    Rowinsky, Eric K.
    Aherne, Wynne
    Atadja, Peter
    Scott, Jeffrey W.
    Patnaik, Amita
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6663 - 6673
  • [36] NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
    Catley, L
    Weisberg, E
    Tai, YT
    Atadja, P
    Remiszewski, S
    Hideshima, T
    Mitsiades, N
    Shringarpure, R
    LeBlanc, R
    Chauhan, D
    Munshi, NC
    Schlossman, R
    Richardson, P
    Griffin, J
    Anderson, KC
    BLOOD, 2003, 102 (07) : 2615 - 2622
  • [37] A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma
    Yamamoto, S
    Yamano, T
    Tanaka, M
    Hoon, DSB
    Takao, S
    Morishita, R
    Aikou, T
    Kaneda, Y
    CANCER GENE THERAPY, 2003, 10 (03) : 179 - 186
  • [38] A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma
    Seiji Yamamoto
    Tomoki Yamano
    Maki Tanaka
    Dave S B Hoon
    Sonshin Takao
    Ryuichi Morishita
    Takashi Aikou
    Yasufumi Kaneda
    Cancer Gene Therapy, 2003, 10 : 179 - 186
  • [39] Conformational Refinement of Hydroxamate-Based Histone Deacetylase Inhibitors and Exploration of 3-Piperidin-3-ylindole Analogues of Dacinostat (LAQ824)
    Cho, Young Shin
    Whitehead, Lewis
    Li, Jianke
    Chen, Christine H-T.
    Jiang, Lei
    Voegtle, Markus
    Francotte, Eric
    Richert, Paul
    Wagner, Trixie
    Traebert, Martin
    Lu, Qiang
    Cao, Xueying
    Dumotier, Berengere
    Fejzo, Jasna
    Rajan, Srinivasan
    Wang, Ping
    Yan-Neale, Yan
    Shao, Wenlin
    Atadja, Peter
    Shultz, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2952 - 2963
  • [40] Characterization of the apoptotic and therapeutic activities of the histone deacetylase inhibitors LAQ824 and LBH589 using a mouse model of B cell lymphoma
    Ellis, Leigh
    Lindemann, Ralph
    Newbold, Andrea
    Whitecross, Kate
    Cluse, Leonie
    Pelligrini, Marc
    Wei, Andrew
    Scott, Clare
    Atadja, Peter
    Lowe, Scott
    Johnstone, Ricky W.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3475S - 3476S
12345